Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to help Parkinson's patients tackle hidden symptoms

NCT ID NCT07038486

Symptom relief Sponsor: Newcastle University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital system called NMS Assist that helps people with Parkinson's and their care partners track non-motor symptoms like pain, sleep problems, and mood changes. 30 participants will use the system for 6 months, and researchers will see if it's easy to use and helps people feel more confident managing their symptoms. The goal is to improve quality of life and make it easier to discuss symptoms with healthcare providers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NMS Assist digital system (device)
What this could lead to
If it works, this could give people with Parkinson's a simple way to track and manage non-motor symptoms at home, improving quality of life and reducing the need for doctor visits.
What could go wrong
This is a very small, early feasibility study with only 30 people. The digital tool may not be easy to use for everyone, and technical issues could limit its effectiveness. It's not designed to treat the disease itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Individuals will be eligible if they meet the following inclusion criteria: All: * Age 18 years or over * Have compatible smartphone/data access (access to a digital device is a necessary prerequisite of system use, and the formative usability study had success in recruiting participants with varying levels of experience with smartphones) * Be fluent in English * Able and willing to provide informed consent * Able and willing to comply with intervention requirements For clinically diagnosed people with Parkinson's (PwP) (ICD-10-CM G20): * Not resident in a care home or nursing home * Ambulant * Interested in monitoring and managing their NMS For CPs: \- Be caring for a clinically diagnosed PwP (ICD-10-CM G20) who is participating in the study Exclusion Criteria: Participants will be ineligible for the study if they meet any of the following exclusion criteria: All: * Previous involvement in the development or testing of the digital system * In a dependent/unequal relationship with the research or care teams or any PPI representatives PwP: * Secondary cause of Parkinsonism * Significant cognitive impairment or a diagnosis of Parkinson's disease dementia * Significant comorbidity, which, in the opinion of the chief investigator, would preclude safe participation in the study or protocol compliance * A life expectancy of \<6 months * Living in residential care facilities

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Newcastle University

    RECRUITING

    Newcastle upon Tyne, Tyne and Wear, NE4 8EA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.